c i t r a t e , a potent short a c t i v i t y narcotic i s being considered f o r o b s t e t r i c a l analgesialanesthesia. Fentanyl i s highly protein bound (67%) and very l i p i d soluble (N-haptane 22), the l a t t e r suggesting rapid placental t r a n s f e r of the unbound drug. We evaluated the k i n e t i c s and placental transfer of Fentanyl i n 5 chronically catheterized pregnant ewe$ (near term) and t h e i r fetuses following intravenous injection of Fentanyl (4 ~.lg/kg). Fentanyl was measured i n s e r i a l blood samples from mat e r n a l a r t e r i a l (MA) blood and f e t a l umbilical a r t e r i a l (UA) and venous blood (UV) by radioimmunoassay. Similar k i n e t i c studies were performed i n 5 newborn lambs.
lndomethacin (1) undergoes both microsomal oxidation to desmethylindomethacin (DM] ) and cytosolic deacylation to desbenzoylchloro-indomethacin (DBI). The in vitro postnatal development of these two pathways was examined in the rabbit liver using collagfiqase-isolated hepatocytes and liver fractions incubated with 0.5 mM C-I and appropriate cofactors for drug metabolism activity. Samples were removed a t 5 to 15 min intervals for analysis of I metabolites. Deacylation of I to DBI in the 10,000g liver homogenate increased rapidly during the 1st 2 wks after births and demonstrated adult values within day 12 of postnatal age. Results from freshly isolated hepatocytes were very similar to the 10,000g liver homogenate in the pattern of postnatal development of the DBI pathway. Oxidative demethylation of I to DM1 in the 10,000g homogenate and isolated cells demonstrated a significant increase only after day 14 of postnatal age and demonstrated only 83% of adult value by day 32 oj postnatal age. The isolated microsomal fraction demonstrated a significant postnatal increase in DM1 formation during the first 2 wks of postnatal life and reached adult values within day 32 of postnatal age. It is postulated that the difference in postnatal development of I metabolism to DM1 between isolated microsomes 'and the 10,000g homogenate or the isolated hepatocyte is due to endogenous substrates which are competitive for oxidative drug metabolism. PENTAZOCINE: EFFECTS ON PREGNANCY AND THE NEONATE. Loretta P. ~i n n e an, Ronald J . Wapner. ~homas 325 -0~Univer:ity Hospital, Departments of Obstetrics/Gynecology and Pediatrics, Philadelphia, Pa.
The e f f e c t s of heroin addiction on pregnancy and the newborn have been profound. With the decrease in quantity and quality of heroin, women have begun t o use other psychoactive agents such as pentazocine. Two groups of pregnant women enrolled in a comprehensive prenatal addiction program were studied: Group A (N=14) whose major drug of abuse was pentazocine; Group B (N=26) were maintained on methadone. Maternal and infant morbidity were compared. In Group A one mother and infant died. Differences were observed i n t h e following parameters:
Group AGA/LBW incidence (%) 23 15 No differences were seen in maternal aqe, gravity, abortions, obstetrical complications, o r newborn Apgar scores. Neonatal abstinence symptoms occurred in a l l infants, and 85% of each group were treated. These data suggest t h a t greater maternal and infant morbidity occur when pentazoci ne, a s compared t o methadone, i s used during pregnancy.
, , , TRANSPLACENTALLY ACQUIRED XANTHINES I N APNEA OF 3LO PREMATURITY. Dennis M. Fisher, Marie Ragni, Maria Delivoria-Papadopoulos, Departments of Anesthesia, Clinical Pharmacology and Neonatology, Hospital of the Univers i t y of Pennsylvania and The children's ~o s~i t a l of Philadelphia Theophylline (T) and Caffeine (C) cross the placenta easily. Because of the ubiquity of xanthines i n the maternal d i e t , we have examined the role of transplacentally acquired xanthines i n apnea of prematurity. W e studied 27 infants, 25-35 weeks gestation, without RDS, hyperbilirubinemia o r sepsis. Group 1 cons i s t e d of 9 who developed apnea within one week of l i f e . Group 2, 18 non-apneic infants, served a s controls. Serum T and C concentrations were measured by HPLC a t b i r t h and d a i l y f o r 7 days o r u n t i l the onset of apnea. Group differences i n b i r t h weight and gestational age were eliminated by analysis of covariance. BIRTH There was no difference (p>0.3) between groups i n b i r t h l e v e l s of T, C, o r T+C ( t h e sum of T and C). In addition there was no difference (p>0.3) f o r T, C, and T+C between Group 1 a t the onset of apnea and trough values from Group 2. These data suggest that transplacentally acquired xanthines play no r o l e i n apnea of prematurity. GFR a n d u r i n e o u t p u t may be more dependent on changes i n mean a r t e r i a l pressure (Pa) i n t h e asphyxiated inf a n t . Theref o r e , t h e d i s p o s i t i o n o f aminoglycosides, which depend on GFR f o r clearance, may be altered. 27 p r e t e r m i n f a n t s ( < 3 5 weeks g e s t a t i o n ) with suspected o r proven s e p s i s were p r o s p e c t i v e l y s t u d i e d . Gentamicin halfl i f e (T1/2) was conpared with t h e following factors: asphyxia, hypotension, and t h e use o f dopamine (5-15ugms/kg.min) a f t e r volume expansion. T1/2 is prolonged i n a s p h y x i a t e d i n f a n t s (12.6 h r s v s 7.2 h r s p=0.05).
T1/2 is n o t a l t e r e d by t h e use of clopamin=
In a s p h y x i a t e d i n £ a n t s (N=8 ) t h e gentamicin T1/2 correlated with u r i n e o u t p u t (r=0.57) and with Pa (r=0.69). These correlations a r e n o t present i n non-asphyxiated infants. The gentanicin peak and trough v a l u e s d i d n o t c o r r e l a t e with s e r i a l urine flow, blood u r e a n i t r o g e n o r creatinine. There is an inverse relationship t o gestational age and post-natal age.
Following p e r i n a t a l asphyxia, auto-regulation of GFR and RBF may be decreased s o t h a t gentamicin T1/2 is m r e dependent on Pa. Gentamicin k i n e t i c s should be c a r e f u l l y monitored i n asphyxiated infants. The excretion of theophyll ine and i t s metabolites was studied in 8 premature infants treated f o r apnea. Changes and differences in metabolic patterns were sought. Theophylline and metabolites were assayed in urine and serum by HPLC. Urine was passed through a Dowex-2 column f o r clean-up prior t o injection. Recovery of compounds by t h i s method.was >95%. In 6 patients, multiple 6 hour urine specimens were assayed.
Theophylline accounted f o r 62% of the total drug and metabolites excreted. The range was 54 t o 95%. 1 , 3 dimethyluric acid (13DMU), the predominant metabolite in adults, accounted f o r 22% of the excreted drug.
I-methyluric acid and 3-methylxanthine comprised the remainder, although caffeine was not quantitated.
In 3 patients, there was a s h i f t t o a larger percentage excretion of l3DMU during therapy suggesting a development of metabolizing capacity. Dosage change in one patient resulted in no change in metabolite pattern.
Differences between patients may be the r e s u l t of genetic v a r i a b i l i t y o r prenatal xenobiotics f o r which information was incomplete in t h i s study.
